Machine Learning News and Research

RSS

Researchers use AI methods to 'redefine' Alzheimer's disease

As the search for successful Alzheimer's disease drugs remains elusive, experts believe that identifying biomarkers -- early biological signs of the disease -- could be key to solving the treatment conundrum.

14 Oct 2020

Advantech Receives 2020 IoT Edge Computing Excellence Award from IoT Evolution World

Irvine, CA (10/09/2020) – Advantech announced today that MIC-730AI, Edge AI Inference System based on NVIDIA Jetson® Xavier has received a 2020 IoT Edge Computing Excellence Award from IoT Evolution World, the leading web site covering the Internet of Things (IoT) marketplace.

14 Oct 2020

New machine learning concepts can help develop novel drugs

Tandem mass spectrometry is a powerful analytical tool used to characterize complex mixtures in drug discovery and other fields.

14 Oct 2020

Researchers explore molecular factors that drive the severity of COVID-19

While most COVID-19 cases are asymptomatic or mild, severe complications associated with acute respiratory distress have led to more than one million deaths worldwide in just several months.

13 Oct 2020

Dynamic map reveals how cells fight microbes and preserve memory for future infections

Researchers have charted the activity of tens of thousands of genes in mouse immune cells over the course of an infection.

12 Oct 2020

New lab-on-a-chip can help study tumor heterogeneity, improve cancer therapies

Electrical engineers, computer scientists and biomedical engineers at the University of California, Irvine have created a new lab-on-a-chip that can help study tumor heterogeneity to reduce resistance to cancer therapies.

8 Oct 2020

Researchers receive NIH grant to investigate link between loneliness and Alzheimer's risk

Two researchers from The Neuro, with collaborators from the StoP-AD Centre at the Douglas Mental Health University Institute and the Quebec Artificial Intelligence Institute, will lead a research program centered on an emerging field of neuroscience thanks to a grant from the National Institutes of Health/National Institute of Aging in the USA.

7 Oct 2020

New algorithm can fast forward quantum simulations to solve problems

A new algorithm that fast forwards simulations could bring greater use ability to current and near-term quantum computers, opening the way for applications to run past strict time limits that hamper many quantum calculations.

6 Oct 2020

New deep learning-based technique could boost drug development

When you take a medication, you want to know precisely what it does. Pharmaceutical companies go through extensive testing to ensure that you do.

5 Oct 2020

Machine learning can predict pediatric ECMO patients at risk of brain injury

When newborn babies or children with heart or lung distress are struggling to survive, doctors often turn to a form of life support that uses artificial lungs.

1 Oct 2020

Study reveals how ILCs develop, adapt, specialize in specific tissue environments

Specialized immune cells settle permanently in various tissues of the body and build "local task forces". Scientists from Würzburg have now discovered, how these cell populations can renew locally and can adapt to their specific environment.

1 Oct 2020

Scientists receive two-year grant to develop tool for treating mood disorders

A team of Georgia State scientists has received a two-year, $875,110 grant from the National Institute of Mental Health to further develop a tool to help psychiatrists treat mood disorders.

1 Oct 2020

VA Boston and BU researchers use machine learning to streamline the diagnostic tool for PTSD

Post-traumatic stress disorder (PTSD) affects eight million adults in the US, including hundreds of thousands of veterans of the conflicts in Iraq and Afghanistan.

30 Sep 2020

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies.

29 Sep 2020